Actinium Pharmaceuticals, Inc.
Records under this name other than the patents Actinium Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 32 patents it holds.
Showing 1 to 6 of 6 · Back to Actinium Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,127,527 | Apparatus for the therapeutic use of .sup.213 Bi Lapsed on the fee record Ended Oct 3, 2012 · From the USPTO record | Lapsed on the fee record | Ended Oct 3, 2012 | From the USPTO record |
| US 7,374,936 | Method and means for site directed therapy Term ended Term ended Mar 23, 2012 · From the USPTO record | Term ended | Term ended Mar 23, 2012 | From the USPTO record |
| US 6,403,771 | Method and means for site directed therapy Term ended Ended no later than Feb 19, 2011 · From the USPTO record | Term ended | Ended no later than Feb 19, 2011 | From the USPTO record |
| US 5,246,691 | Radioimmunotherapy using .alpha.-particles emission Term ended Term ended no later than Sep 21, 2013 · Low confidence | Term ended | Term ended no later than Sep 21, 2013 | Low confidence |
| US 5,457,323 | Process for stripping radon-220 from radioactive isotope mixture Term ended Term ended no later than Oct 10, 2015 · Low confidence | Term ended | Term ended no later than Oct 10, 2015 | Low confidence |
| US 5,641,471 | Method for preparing .sup.213 Bi for therapeutic use Formerly held Term ended Term ended no later than Jun 24, 2017 · Low confidence | Term ended | Term ended no later than Jun 24, 2017 | Low confidence |